ConductScience.org, home

Paper8777280

Glucagon-like-peptide-1 (7-36) amide improves glucose sensitivity in beta-cells of NOD mice.

Linn T and 3 others. Acta Diabetol, 1996. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Glucagon-like-peptide-1 (7-36) amide improves glucose sensitivity in beta-cells of NOD mice. Papers, record 8777280. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8777280

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Glucagon-like-peptide-1 (7-36) amide improves glucose sensitivity in beta-cells of NOD mice.
PubMed
Journal
Acta Diabetol
PubMed
Year
1996
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.27
iCite
Revised in PubMed
2026-10-10
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Linn TT
2Schneider KK
3Göke BB
4Federlin KK

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetes Mellitus, Type 2Major topic
GlucoseMajor topic
InsulinMajor topic
Islets of LangerhansMajor topic
Peptide FragmentsMajor topic
Animals
Cells, Cultured
Glucagon
Glucagon-Like Peptide 1
Glucagon-Like Peptides
In Vitro Techniques
Insulin Secretion
Kinetics
Mice
Mice, Inbred NOD
Mice, Mutant Strains
Pancreas
Time Factors

Source PubMed

Download CSV of topics

References24

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18516568Glucose-dependency of the insulin stimulatory effect of glucagon-like peptide-1 (7-36) amide on the rat pancreas.Res Exp Med (Berl)1993https://conductscience.org/library/papers/8516568PubMed
28423228Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.J Clin Invest1993https://conductscience.org/library/papers/8423228PubMed
38446036Glucagon-like peptide-I-(7-37) suppresses hyperglycemia in rats.Metabolism1993https://conductscience.org/library/papers/8446036PubMed
43264405Prevention of diabetes in nonobese diabetic mice by anti-I-A monoclonal antibodies: transfer of protection by splenic T cells.Proc Natl Acad Sci U S A1988https://conductscience.org/library/papers/3264405PubMed
57517895Signal transduction of the GLP-1-receptor cloned from a human insulinoma.FEBS Lett1994https://conductscience.org/library/papers/7517895PubMed
61348845Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus.N Engl J Med1992https://conductscience.org/library/papers/1348845PubMed
78381211Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37).Nature1993https://conductscience.org/library/papers/8381211PubMed
88405712Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor.Diabetes1993https://conductscience.org/library/papers/8405712PubMed
92171911Interleukin-1 beta depletes insulin messenger ribonucleic acid and increases the heat shock protein hsp70 in mouse pancreatic islets without impairing the glucose metabolism.Endocrinology1990https://conductscience.org/library/papers/2171911PubMed
103902545New developments in the incretin concept.Diabetologia1985https://conductscience.org/library/papers/3902545PubMed
117905842International Symposium on Glucagon-Like Peptide-1. Copenhagen, Denmark, May 17-19, 1993. Abstracts.Digestion1993https://conductscience.org/library/papers/7905842PubMed
121705823Priming effect of glucagon-like peptide-1 (7-36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas.Biochim Biophys Acta1991https://conductscience.org/library/papers/1705823PubMed
132245873Elusive proximal signals of beta-cells for insulin secretion.Diabetes1990https://conductscience.org/library/papers/2245873PubMed
141647951Glucagon-like peptide-1(7-36) amide is a new incretin/enterogastrone candidate.Eur J Clin Invest1991https://conductscience.org/library/papers/1647951PubMed
151565148The enteroinsular axis revisited. A novel role for an incretin.N Engl J Med1992https://conductscience.org/library/papers/1565148PubMed
168036284The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects.Regul Pept1994https://conductscience.org/library/papers/8036284PubMed
178112494Detection of the human glucagon-like peptide 1(7-36) amide receptor on insulinoma-derived cell membranes.Digestion1994https://conductscience.org/library/papers/8112494PubMed
188307251Spontaneous glucose intolerance in the progeny of low dose streptozotocin-induced diabetic mice.Diabetologia1993https://conductscience.org/library/papers/8307251PubMed
192645190Glucagonlike peptide I (7-37) actions on endocrine pancreas.Diabetes1989https://conductscience.org/library/papers/2645190PubMed
202564338Comparison of the effects of glucagon-like peptide-1-(1-37) and -(7-37) and glucagon on islet hormone release from isolated perfused canine and rat pancreases.Endocrinology1989https://conductscience.org/library/papers/2564338PubMed

See all 24 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
41984373Glucagon-Like Peptide-1 Receptor Agonists: Their Potential Role in Prediabetes.Diabetes Ther2026https://conductscience.org/library/papers/41984373PubMed
39101164Effects of dulaglutide and trelagliptin on beta-cell function in patients with type 2 diabetes: a randomized controlled study: DUET-beta study.Diabetol Int2024https://conductscience.org/library/papers/39101164PubMed
35273901Repurposing of existing antibiotics for the treatment of diabetes mellitus.In Silico Pharmacol2022https://conductscience.org/library/papers/35273901PubMed
28270518Myricetin: a potent approach for the treatment of type 2 diabetes as a natural class B GPCR agonist.FASEB J2017https://conductscience.org/library/papers/28270518PubMed
27212208Novel application of hydrophobin in medical science: a drug carrier for improving serum stability.Sci Rep2016https://conductscience.org/library/papers/27212208PubMed
20491795The Type 1 Diabetes PhysioLab Platform: a validated physiologically based mathematical model of pathogenesis in the non-obese diabetic mouse.Clin Exp Immunol2010https://conductscience.org/library/papers/20491795PubMed
18063685Exendin-4 modulates diabetes onset in nonobese diabetic mice.Endocrinology2008https://conductscience.org/library/papers/18063685PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8777280

GET https://conductscience.org/api/papers/v1/8777280/references?page=2